Back

Vaccine effectiveness of Ad26.COV2.S against symptomatic COVID-19 and clinical outcomes in Brazil: a test-negative study design

2021-10-18 epidemiology Title + abstract only
View on medRxiv
Show abstract

We used a test-negative design to estimate the vaccine effectiveness of Ad26.COV2.S (Janssen) against symptomatic COVID-19 and clinical outcomes in Mato-Grosso do Sul, Brazil. We analyzed 11,817 RT-PCR tests. The mean age was 37 (SD=17) years, 2,308 (20%) of individuals more or equal than 50 years and almost two-thirds of the population was Brown/Pardo. Adjusted effectiveness against symptomatic COVID-19 after 28 days of the single dose was 50.9% (95% CI, 35.5-63.0). Adjusted effectiveness again...

Predicted journal destinations

1
PLOS ONE
1737 training papers
Top 50% 13.4%
2
Clinical Infectious Diseases
219 training papers
Top 5% 5.9%
3
Nature Communications
483 training papers
Top 19% 5.9%
4
Scientific Reports
701 training papers
Top 52% 5.5%
5
Vaccines
131 training papers
Top 2% 4.6%
6
Eurosurveillance
77 training papers
Top 0.8% 4.6%
7
The Lancet Infectious Diseases
57 training papers
Top 0.8% 3.5%
8
Vaccine
140 training papers
Top 3% 3.5%
9
International Journal of Infectious Diseases
115 training papers
Top 4% 3.5%
10
Epidemiology and Infection
80 training papers
Top 3% 2.6%
11
The Lancet Regional Health - Americas
20 training papers
#1 2.6%
12
The Journal of Infectious Diseases
137 training papers
Top 8% 1.8%
13
BMC Medicine
155 training papers
Top 14% 1.8%
14
New England Journal of Medicine
49 training papers
Top 1% 1.8%
15
Frontiers in Public Health
135 training papers
Top 22% 1.4%
16
Emerging Infectious Diseases
84 training papers
Top 9% 1.4%
17
BMC Infectious Diseases
110 training papers
Top 14% 1.4%
18
BMC Public Health
148 training papers
Top 22% 1.4%
19
Open Forum Infectious Diseases
124 training papers
Top 10% 1.4%
20
Journal of Medical Virology
95 training papers
Top 9% 1.2%
21
The Lancet Regional Health - Europe
32 training papers
Top 0.6% 1.2%
22
Frontiers in Medicine
99 training papers
Top 15% 1.2%
23
BMJ Open
553 training papers
Top 59% 1.2%
24
BMJ
49 training papers
Top 4% 1.2%
25
Clinical Microbiology and Infection
54 training papers
Top 6% 1.1%
26
International Journal of Epidemiology
65 training papers
Top 9% 1.1%
27
Communications Medicine
63 training papers
Top 4% 1.1%
28
Nature Medicine
88 training papers
Top 15% 0.9%
29
PLOS Medicine
95 training papers
Top 19% 0.9%
30
Journal of Infection
64 training papers
Top 9% 0.9%